- •Type 2 diabetes is associated with changes in distribution of muscle.
- •Central lean mass distribution is linked to risk of death in type 2 diabetes.
- •The association is independent of cardiovascular risk factors and leg lean mass.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025.Sci. Rep. 2020; 10: 14790https://doi.org/10.1038/s41598-020-71908-9
- Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition.Diabetes Res. Clin. Pract. 2020; 162108086https://doi.org/10.1016/j.diabres.2020.108086
- Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes.New Engl. J. Med. 2018; 379: 633-644https://doi.org/10.1056/NEJMoa1800256
- Risk factors for mortality among patients with diabetes: the translating research into action for diabetes (TRIAD) study.Diabetes Care. 2007; 30: 1736-1741https://doi.org/10.2337/dc07-0305
- Predicting 5- and 10-Year mortality risk in older adults with diabetes.Diabetes Care. 2020; 43: 1724-1731https://doi.org/10.2337/dc19-1870
- Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.Diabetes Care. 2009; 32: S157-S163https://doi.org/10.2337/dc09-S302
- Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases.Lancet Diabetes Endocrinol. 2014; 2: 819-829https://doi.org/10.1016/s2213-8587(14)70034-8
Horton W.B., Barrett E.J. Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease. Endocrine reviews. 2020.
- Body composition in type 2 diabetes: change in quality and not just quantity that matters.Int. J. Prev. Med. 2015; 6: 122https://doi.org/10.4103/2008-7802.172376
- Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging.J. Am. Med. Dir. Assoc. 2013; 14: 585-592https://doi.org/10.1016/j.jamda.2013.02.006
- Excessive loss of skeletal muscle mass in older adults with type 2 diabetes.Diabetes Care. 2009; 32: 1993-1997https://doi.org/10.2337/dc09-0264
- Muscle-organ crosstalk: the emerging roles of myokines.Endocr. Rev. 2020; 41: 594-609https://doi.org/10.1210/endrev/bnaa016
- Low skeletal muscle mass is associated with the risk of all-cause mortality in patients with type 2 diabetes mellitus.Ther. Adv. Endocrinol. Metab. 2019; 10 (2042018819842971)https://doi.org/10.1177/2042018819842971
- Psoas and paraspinous muscle index as a predictor of mortality in African American men with type 2 diabetes mellitus.J. Diabetes Complicat. 2018; 32: 558-564https://doi.org/10.1016/j.jdiacomp.2018.03.004
- Psoas and paraspinous muscle measurements on computed tomography predict mortality in European Americans with type 2 diabetes mellitus.J. Frailty Aging. 2019; 8: 72-78https://doi.org/10.14283/jfa.2019.5
- The evidence for an obesity paradox in type 2 diabetes mellitus.Diabetes Metab. J. 2018; 42: 179-187https://doi.org/10.4093/dmj.2018.0055
- Association between lower extremity skeletal muscle mass and impaired cognitive function in type 2 diabetes.Sci. Rep. 2020; 10: 2956https://doi.org/10.1038/s41598-020-59914-3
- Lower extremity skeletal muscle mass, but not upper extremity skeletal muscle mass, is inversely associated with hospitalization in patients with type 2 diabetes.J. Diabetes Res. 2017; 2017: 2303467https://doi.org/10.1155/2017/2303467
- Central obesity and visceral adipose tissue are not associated with incident atherosclerotic cardiovascular disease events in older men.J. Am. Heart Assoc. 2018; 7e009172https://doi.org/10.1161/JAHA.118.009172
- Different indicators of adiposity and fat distribution and cardiometabolic risk factors in patients with type 2 diabetes.Obesity. 2021; 29: 837-845https://doi.org/10.1002/oby.23151
- Cardiovascular risk factor status in hospitalized patients with type 2 diabetes in China.Front. Endocrinol. 2021; 12664183https://doi.org/10.3389/fendo.2021.664183
- A new equation to estimate glomerular filtration rate.Ann. Intern. Med. 2009; 150: 604-612https://doi.org/10.7326/0003-4819-150-9-200905050-00006
- Altered body composition in type 2 diabetes mellitus.Int. J. Obes. 2005; 32 (2008): 780-787https://doi.org/10.1038/sj.ijo.0803802
- Distribution patterns of intramyocellular and extramyocellular fat by magnetic resonance imaging in subjects with diabetes, prediabetes and normoglycaemic controls.Diabetes, Obes. Metab. 2021; 23: 1868-1878https://doi.org/10.1111/dom.14413
- Intermuscular fat: a review of the consequences and causes.Int. J. Endocrinol. 2014; 2014309570https://doi.org/10.1155/2014/309570
- Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver.Nat. Rev. Endocrinol. 2021; 17: 47-66https://doi.org/10.1038/s41574-020-00431-8
- Sex differences in body composition and association with cardiometabolic risk.Biol. Sex. Differ. 2018; 9: 28https://doi.org/10.1186/s13293-018-0189-3
- Altered intramuscular lipid metabolism relates to diminished insulin action in men, but not women, in progression to diabetes.Obesity. 2010; 18: 2093-2100https://doi.org/10.1038/oby.2010.76.29
- Correlation between diabetic peripheral neuropathy and sarcopenia in patients with type 2 diabetes mellitus and diabetic foot disease: a cross-sectional study.Diabetes Metab. Syndr. Obes. Targets Ther. 2020; 13: 377-386https://doi.org/10.2147/dmso.S237362
- Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship.Diabetes Metab. Syndr. Obes. Targets Ther. 2019; 12: 1057-1072https://doi.org/10.2147/dmso.S186600
- Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes.Obes. Rev. Off. J. Int. Assoc. Study Obes. 2019; 20: 1205-1217https://doi.org/10.1111/obr.12862
- Reduced lower-limb muscle strength and volume in patients with type 2 diabetes in relation to neuropathy, intramuscular fat, and vitamin D levels.Diabetes Care. 2016; 39: 441-447https://doi.org/10.2337/dc15-0995
- Comparison of lean mass indices as predictors of mortality in incident peritoneal dialysis patients.PloS One. 2021; 16 (e0254942-e)https://doi.org/10.1371/journal.pone.0254942
- Limb/trunk lean mass ratio as a risk factor for mortality in peritoneal dialysis patients.J. Ren. Nutr. Off. J. Counc. Ren. Nutr. Natl. Kidney Found. 2013; 23: 315-323https://doi.org/10.1053/j.jrn.2012.09.004
- Diabetes pharmacotherapy and effects on the musculoskeletal system.Diabetes Metab. Res. Rev. 2019; 35e3100https://doi.org/10.1002/dmrr.3100
- A review of the effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans.Endocrinol. Metab. 2019; 34: 247-262https://doi.org/10.3803/EnM.2019.34.3.247
- Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013.Jama. 2017; 317: 2515-2523https://doi.org/10.1001/jama.2017.7596
- Phenotypic and genetic characterization of Lower LDL cholesterol and increased type 2 diabetes risk in the UK Biobank.Diabetes. 2020; 69: 2194-2205https://doi.org/10.2337/db19-1134
- Body-mass index and all-cause mortality in US adults with and without diabetes.J. Gen. Intern. Med. 2014; 29: 25-33https://doi.org/10.1007/s11606-013-2553-7
- Ethnic-specific obesity cutoffs for diabetes risk: cross-sectional study of 490,288 UK biobank participants.Diabetes Care. 2014; 37: 2500-2507https://doi.org/10.2337/dc13-2966